EPISODE · Jul 14, 2016 · 9 MIN
Nivolumab Monotherapy is Safe and Active in Hematologic Malignancies
from Journal of Clinical Oncology (JCO) Podcast · host Jason R. Westin
This podcast is a discussion of a clinical trial by Lesokhin et al which evaluated nivolumab monotherapy in patients with relapsed or refractory hematologic malignancies.
NOW PLAYING
Nivolumab Monotherapy is Safe and Active in Hematologic Malignancies
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m